Ticker Launch

SPAC · Merger completed

ARYA Sciences Acquisition Corp II

Business combination with Cerevel Therapeutics, Inc.

ARYA Sciences Acquisition Corp II is a blank-check company (SPAC) that raised $130M in its initial public offering on Jun 8, 2020, listing on Nasdaq Capital Market. It completed its business combination with Cerevel Therapeutics, Inc. on Oct 27, 2020; the combined company is Cerevel Therapeutics Holdings, Inc. (CERE). Kirkland & Ellis advised the SPAC and Skadden, Arps advised the underwriters on the IPO.

Status
Merger completed
IPO date
Jun 8, 2020
IPO size
$130M
IPO exchange
Nasdaq Capital Market
Target
Cerevel Therapeutics, Inc.
Announced
Jul 30, 2020
Closed
Oct 27, 2020
Combined company
Cerevel Therapeutics Holdings, Inc. (CERE)
SPAC counsel (IPO)
Kirkland & Ellis and Ogier
Underwriters' counsel (IPO)
Skadden, Arps

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2020